Transurethral resection of the prostate across continents: a meta-analysis evaluating quality of gold standard in the twenty-first century
Authors:
- Joao G. PortoJPJoao G. Porto
- Ansh M. BhatiaABAnsh M. Bhatia
- Maria Camila Suarez ArbelaezMAMaria Camila Suarez Arbelaez
- Ruben Blachman-BraunRBRuben Blachman-Braun
- Khushi ShahKSKhushi Shah
- Ankur MalpaniAMAnkur Malpani
- Diana LopateguiDLDiana Lopategui
- Thomas R. W. HerrmannTHThomas R. W. Herrmann
- Hemendra N. ShahHSHemendra N. Shah
Open Access
- 24 January 2025
- journal article
- review article
- Published by Springer Nature in World Journal of Urology
- Vol. 43 (1) , 1-37
Abstract
Purpose: To compare outcomes of transurethral resection of the prostate (TURP) across different regions worldwide over the past two decades. Methods: A systematic review and meta-analysis of randomized clinical trials indexed to PubMed that assessed TURP. A total of 102 studies with 8,454 patients were included and grouped by continents: Europe, Asia, Africa, and Others (North America, South America, and Australia). International Prostate Symptom Score (IPSS), peak flow (Qmax), postvoid residual urine (PVR), PSA levels, prostate volume, and Sexual Health Inventory for Men scores (at 3, 12, and 36 months) were assessed, along with postoperative complications. Heterogeneity across studies was classified as low (I 2 < 25%), moderate (I 2 = 25–75%), or high (I 2 > 75%). Results: TURP consistently exhibited significant enhancements in IPSS, Qmax, and PVR across various regions. Notably, PVR demonstrated high heterogeneity (I²=100%). TURP presented low complication rates with TURP syndrome (2%), bleeding (8%), and blood transfusion (6%). However, significant heterogeneity was observed, particularly for clot evacuation (I 2 = 87%), irritative symptoms (I 2 = 96%), and incontinence (I 2 = 84%). The retreatment rates at 1 and 3 years were 5% and 7%, respectively, with significant differences across regions. Conclusion: Global outcomes of TURP lack a discernible trend. The substantial heterogeneity observed among continents suggests a lack of standardization. Nevertheless, uniform symptomatic improvements among patients still support TURP as the gold-standard surgical treatment for benign prostatic hyperplasia, despite variations in its results worldwide.Keywords
This publication has 159 references indexed in Scilit:
- Prostatic Artery Embolization Versus Transurethral Resection of the Prostate: A Post Hoc Cost Analysis of a Randomized Controlled Clinical TrialCardioVascular and Interventional Radiology, 2021
- Online interest in surgical treatment for benign prostatic hyperplasia using Google trendsWorld Journal of Urology, 2020
- Monopolar enucleation versus transurethral resection of the prostate for small- and medium-sized (< 80 cc) benign prostate hyperplasia: a prospective analysisWorld Journal of Urology, 2019
- Do patients have to choose between ejaculation and miction? A systematic review about ejaculation preservation technics for benign prostatic obstruction surgical treatmentWorld Journal of Urology, 2018
- HoLEP provides a higher prostate cancer detection rate compared to bipolar TURP: a matched-pair analysisWorld Journal of Urology, 2018
- Prospective randomized study comparing monopolar with bipolar transurethral resection of prostate in benign prostatic obstruction: 36-month outcomesWorld Journal of Urology, 2017
- Transurethral Resection of the Prostate (TURP) Versus Original and PErFecTED Prostate Artery Embolization (PAE) Due to Benign Prostatic Hyperplasia (BPH): Preliminary Results of a Single Center, Prospective, Urodynamic-Controlled AnalysisCardioVascular and Interventional Radiology, 2015
- A randomized trial comparing thulium laser resection to standard transurethral resection of the prostate for symptomatic benign prostatic hyperplasia: four-year follow-up resultsWorld Journal of Urology, 2013
- The effect of urinary incontinence on health utility and health‐related quality of life in men following prostate surgeryNeurourology and Urodynamics, 2012
- Sexual functions in patients with benign prostatic hyperplasia before and after transurethral resection of the prostateUrological Research, 1998